​

Omada Health Stock (NASDAQ:OMDA)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$19.72

52W Range

$10.28 - $26.92

50D Avg

$22.02

200D Avg

$17.16

Market Cap

$1.17B

Avg Vol (3M)

$1.38M

Beta

1.85

Div Yield

-

OMDA Company Profile


Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

946

IPO Date

Jun 06, 2025

Website

OMDA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25
Service$241.04M
Hardware$37.43M

Fiscal year ends in Dec 25 | Currency in USD

OMDA Financial Summary


Dec 25Dec 24Dec 23
Revenue$260.21M$169.80M$122.78M
Operating Income$-11.97M$-43.65M$-66.00M
Net Income$-12.78M$-47.14M$-67.51M
EBITDA$-6.48M$-37.83M$-58.36M
Basic EPS$-0.22$-0.85$-1.21
Diluted EPS$-0.22$-0.85$-1.21

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q2 26Aug 06, 26 | 4:30 PM
Q1 26May 07, 26 | 4:30 PM
Q4 25Mar 05, 26 | 4:30 PM

Peer Comparison


TickerCompany
TDOCTeladoc Health, Inc.
OMCLOmnicell, Inc.
PGNYProgyny, Inc.
UFPTUFP Technologies, Inc.
SDGRSchrödinger, Inc.
TXG10x Genomics, Inc.
BCRXBioCryst Pharmaceuticals, Inc.
PHRPhreesia, Inc.
XERSXeris Biopharma Holdings, Inc.
MAZEMaze Therapeutics, Inc.